PRFX

PainReform Ltd. is a pioneering pharmaceutical firm headquartered in Tel Aviv, Israel, focused on advancing post-surgical pain management through its innovative proprietary drug delivery technology. By enhancing the safety and efficacy of analgesics, the company tackles pressing challenges in the management of postoperative pain, positioning itself as a frontrunner in the dynamic pain management landscape. PainReform’s dedication to improving patient outcomes not only underscores its potential to revolutionize healthcare practices but also makes it an attractive investment opportunity for institutional investors seeking exposure to cutting-edge medical therapies.